Gebel HM - Search Results

1

De novo DQ donor-specific antibodies are associated with worse outcomes compared to non-DQ de novo donor-specific antibodies following heart transplantation.

Cole RT, Gandhi J, Bray RA, Gebel HM, Morris A, McCue A, Yin M, Laskar SR, Book W, Jokhadar M, Smith A, Nguyen D, Vega JD, Gupta D. Cole RT, et al. Among authors: gebel hm. Clin Transplant. 2017 Apr;31(4). doi: 10.1111/ctr.12924. Epub 2017 Mar 5. Clin Transplant. 2017. PMID: 28181305

2

Conundrums with FlowPRA beads.

Gebel HM, Harris SB, Zibari G, Bray RA. Gebel HM, et al. Clin Transplant. 2002;16 Suppl 7:24-9. doi: 10.1034/j.1399-0012.16.s7.3.x. Clin Transplant. 2002. PMID: 12372040

3

Pre-transplant assessment of donor-reactive, HLA-specific antibodies in renal transplantation: contraindication vs. risk.

Gebel HM, Bray RA, Nickerson P. Gebel HM, et al. Am J Transplant. 2003 Dec;3(12):1488-500. doi: 10.1046/j.1600-6135.2003.00273.x. Am J Transplant. 2003. PMID: 14629279 Free article. No abstract available.

4

Approaches for transplanting the sensitized patient: biology versus pharmacology.

Gebel HM, Bray RA. Gebel HM, et al. Nephrol Dial Transplant. 2008 Aug;23(8):2454-7. doi: 10.1093/ndt/gfn108. Epub 2008 Mar 25. Nephrol Dial Transplant. 2008. PMID: 18364369 Review. No abstract available.

5

Strategies for human leukocyte antigen antibody detection.

Bray RA, Gebel HM. Bray RA, et al. Among authors: gebel hm. Curr Opin Organ Transplant. 2009 Aug;14(4):392-7. doi: 10.1097/mot.0b013e32832d31c7. Curr Opin Organ Transplant. 2009. PMID: 19610172 Review.

6

Technical aspects of HLA antibody testing.

Gebel HM, Liwski RS, Bray RA. Gebel HM, et al. Curr Opin Organ Transplant. 2013 Aug;18(4):455-62. doi: 10.1097/MOT.0b013e32836361f1. Curr Opin Organ Transplant. 2013. PMID: 23838651 Review.

7

Influence of race/ethnic differences in pre-transplantation panel reactive antibody on outcomes in heart transplant recipients.

Morris AA, Cole RT, Veledar E, Bellam N, Laskar SR, Smith AL, Gebel HM, Bray RA, Butler J. Morris AA, et al. Among authors: gebel hm. J Am Coll Cardiol. 2013 Dec 17;62(24):2308-15. doi: 10.1016/j.jacc.2013.06.054. Epub 2013 Aug 28. J Am Coll Cardiol. 2013. PMID: 23994416 Free article.

8

Racial differences in the development of de-novo donor-specific antibodies and treated antibody-mediated rejection after heart transplantation.

Cole RT, Gandhi J, Bray RA, Gebel HM, Yin M, Shekiladze N, Young A, Grant A, Mahoney I, Laskar SR, Gupta D, Bhatt K, Book W, Smith A, Nguyen D, Vega JD, Morris AA. Cole RT, et al. Among authors: gebel hm. J Heart Lung Transplant. 2018 Apr;37(4):503-512. doi: 10.1016/j.healun.2017.11.003. Epub 2017 Nov 4. J Heart Lung Transplant. 2018. PMID: 29198929

9

Comparison of de novo IgM and IgG anti-HLA DSAs between belatacept- and calcineurin-treated patients: An analysis of the BENEFIT and BENEFIT-EXT trial cohorts.

Everly MJ, Roberts M, Townsend R, Bray RA, Gebel HM. Everly MJ, et al. Among authors: gebel hm. Am J Transplant. 2018 Sep;18(9):2305-2313. doi: 10.1111/ajt.14939. Epub 2018 Jun 16. Am J Transplant. 2018. PMID: 29767445 Free article. Clinical Trial.

10

A diagnostic 'C' saw: the ups and downs of C1q testing.

Gebel HM, Bray RA. Gebel HM, et al. Curr Opin Organ Transplant. 2019 Aug;24(4):402-410. doi: 10.1097/MOT.0000000000000659. Curr Opin Organ Transplant. 2019. PMID: 31135562 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

194 results

Search Page